At a glance
- Originator Roche
- Class Neuroprotectants; Small molecules
- Mechanism of Action Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Neurological disorders
Most Recent Events
- 26 Jun 2001 No-Development-Reported for Alzheimer's disease in Switzerland (Unknown route)
- 26 Jun 2001 No-Development-Reported for Neurological disorders in Switzerland (Unknown route)
- 02 Dec 1996 Preclinical development for Neurological disorders in Switzerland (Unknown route)